Locations:
Search IconSearch
October 4, 2016/Cancer/News & Insight

New Cancer Building Maximizes Multidisciplinary Care

A concentration of providers and services improve patients’ experience

Cleveland Clinic_Taussig_DuskFacade_FromSouthWest

Providing multidisciplinary care for patients is the norm at Cleveland Clinic Cancer Center, but the cancer building itself has made the process far more efficient for patients and physicians.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In the past, cancer patients getting outpatient treatment traveled to multiple locations within the old Cancer Center building and among other Cleveland Clinic buildings to see specialists, undergo tests and procedures, and receive medical and social services. Sometimes those appointments were spread over more than one day.

With consolidated offices and clinical facilities and advanced scheduling, Cleveland Clinic Cancer Center minimizes transit and wait times and maximizes convenience. “All of the services we need are set up to happen in the same place,” says Nathan Pennell, MD, PhD, Director of the Thoracic Malignancies Program. “The patients are in one place that’s tailored to their needs and everyone comes to them.”

A concentration of providers and services

Lung cancer care provides a good example of how the seven-floor, 385,000-square foot building streamlines operations.

Lung cancer patients who need diagnostic imaging or radiotherapy have access to those services in the lower level — a skylighted, high-ceiling space that contains six linear accelerators, a Gamma Knife® stereotactic radiosurgery unit and a diagnostic imaging suite.

The building’s first floor houses the patient reception area, an expansive hematology laboratory and blood-drawing stations to eliminate waiting lines, a retail pharmacy, and patient services including a café, wellness center, spiritual area, wig boutique and art and music therapy facilities.

Lobby_staged

Lung cancer patients see clinical specialists and receive chemotherapy on the third floor. There, examination rooms surround a meeting/working area where members of the lung cancer multidisciplinary team, including oncologists, surgeons, radiologists, palliative care providers, oncology nurses and advanced practice providers, can discuss therapeutic decisions and treatment plans. Private chemotherapy infusion rooms, a short walk from the examination area, have floor-to-ceiling windows overlooking a tree-lined lawn.

Advertisement

clinicaltreatment_550x450

The second floor contains a dedicated area where patients with lung cancer or other malignancies who are participating in phase I clinical trials receive chemotherapy infusion while being monitored by specially trained nurses and research assistants. The space and staffing reflects Cleveland Clinic Cancer Center’s aggressive efforts to expand phase I clinical trials access for patients.

A more efficient process

“We already had good multidisciplinary care, but I think it was a bit disjointed from the patient perspective,” Dr. Pennell says. “While the patient may have seen a surgeon and radiation and medical oncologists and a palliative medicine physician all in the same day, those visits were often spread out — seeing different people and walking back and forth to different places.

“The idea of the multidisciplinary clinic is that the patient is in one room and multiple doctors will see that person back to back and then consult to plan ongoing care,” Dr. Pennell says. In the past those discussions often took place at weekly tumor board meetings.

“From a care standpoint, it is definitely much more efficient for us to discuss the patient while working in the same space and sitting next to each other, Dr. Pennell says, “so that by the end of the day when the patient is ready to leave, he or she has a plan for treatment.”

Advertisement

Related Articles

PET scan
March 4, 2025/Cancer/News & Insight
Case Study: First Patient at Cleveland Clinic Treated with Tumor-Infiltrating Lymphocyte Therapy

Highly personalized treatment shrinks tumors resistant to immunotherapy

cells with idiopathic multicentric Castleman Disease
February 20, 2025/Cancer/News & Insight
Study Offers New Insights into Idiopathic Multicentric Castleman Disease

Highlighting treatment gaps and challenges in the management of rare condition

CAR T-cell therapy
February 18, 2025/Cancer/News & Insight
Top Myths About CAR T-Cell Therapy for Multiple Myeloma

Explaining common misconceptions about chimeric antigen receptor therapy

Silhouettes of man and woman
February 7, 2025/Cancer/News & Insight
Pharmacokinetics of Many Anticancer Drugs Differ Among Sexes

Slower drug elimination from the body among females may impact safety and efficacy

Mobile mammography van
February 6, 2025/Cancer/News & Insight
Increasing Breast Cancer Screening in Women Experiencing Homelessness

Partnerships with local social service agencies key to program success

Specialty pharmacy
January 24, 2025/Cancer/News & Insight
Researchers Seek Actionable Ways to Reduce Time to Treatment of Multiple Myeloma

Study examines modifiable determinants of health disparities

Woman wearing pink scarf
January 17, 2025/Cancer/News & Insight
Exceptional Responders to Metastatic Breast Cancer Treatment Characterized

Findings may guide future research and personalized treatments

Ad